『Skin and Joints Podcast』のカバーアート

Skin and Joints Podcast

Skin and Joints Podcast

著者： Mimi Tran Aaron Sihota Danny Mansour Ashley Yip Julia Tan Touraj Khosravi Anastasiya Muntyanu
無料で聴く

このコンテンツについて

 A national multidisciplinary masterclass exploring inflammatory skin and joint related conditions led by healthcare experts from across Canada and the US.2024 Skin and Joints Podcast 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • PART 1: What's New in Atopic Dermatitis at AAD 2025 with Dr. Wei Jing Loo

    PART 1: What's New in Atopic Dermatitis at AAD 2025 with Dr. Wei Jing Loo
    2025/04/07

    🎙️PART 1: From Dupilumab to Abrocitinib🩺✨

    Sun-kissed Orlando sets the stage as we talk all things eczema from dupilumab to abrocitinib—after squeezing in a little Disney magic, of course.

    Listen to fresh poster data on switching stubborn AD patients from dupilumab to abrocitinib and debate whether to hit hard with 200 mg or start slow at 100 mg. Rapid EASI-90 gains, itch-free nights, and a “flat-line” durability curve you’ll actually love?

    Along the way you’ll hear:

    • The secret sauce for counseling risk-averse AD patients who’ve already weathered methotrexate and cyclosporine.
    • Why comorbid alopecia or vitiligo might tip you toward a JAK-first strategy.

    🎯 Learning Objectives
    • Identify the clinical profile of AD patients who fail or can’t tolerate dupilumab and may benefit from switching to a JAK inhibitor.
    • Compare real-world efficacy & speed of response between abrocitinib 100 mg vs 200 mg, and craft pragmatic dose-titration plans.
    • Integrate patient-reported outcomes (itch, DLQI) and comorbidity considerations into shared decision-making for advanced AD therapy.

    #SkinAndJointsPodcast #AAD2025 #AtopicDermatitis #EczemaCare #JAKinhibitors #Dupilumab #Abrocitinib #DermTwitter #MedEd #Podcast 🎧

    SUPPORTED BY AN IME GRANT FROM PFIZER.

    About Dr Wei Jing Loo, BSc (Med), MBBS, MRCP (UK), FRCP(c)

    Dermatologist | London, ON

    Dr Wei Jing Loo is the owner and Medical Director of DermEffects, a cutting edge dermatology centre located in London, Ontario. Dr Loo completed medical school in 1997 with an honours degree from the University of New South Wales in Sydney, Australia. She trained in Internal Medicine and obtained membership in the Royal College of Physicians in the United Kingdom in 1999. She completed her dermatology residency training in Cambridge, United Kingdom and obtained her Certificate of Specialist Training in Dermatology in 2005. She is board certified in Canada and a fellow of the Royal College of Physicians and Surgeons of Canada. She is a member of the Canadian Dermatology Association and American Academy of Dermatology. Dr. Loo is at the forefront of the dynamic field of dermatology, serving as an associate investigator for Probity Medical Research. Dr. Loo is an Adjunct Professor at Western University in Ontario. She enjoys teaching and has published her work in many peer-reviewed journals

    📻www.skinandjoints.ca

    ✉️info@skinandjoints.ca

    📻www.skinandjoints.ca

    ✉️info@skinandjoints.ca
    続きを読む 一部表示
    28 分
  • To Switch or Not to Switch? With Dr. Jensen Yeung and Dr. Ron Vender

    To Switch or Not to Switch? With Dr. Jensen Yeung and Dr. Ron Vender
    2025/05/28
    🎙️ Our PsO Playbook: Brothers on the Fairway, Biologics Experts in the Clinic ⛳️🧬✨What happens when two Ontario derms swap the golf course for the Skin and Joints studio? You get a rapid-fire, real-world deep dive into bimekizumab for plaque psoriasis—complete with candid golf confessions, myth-busting on intra-class switching, and a candidiasis reality check you can actually use.Dr. Ron Vender (80 rounds a season 🙌) and Dr. Jensen Yeung (proud caddy and data devotee) unpack their 16-week, multicentre retrospective review of adults with moderate to severe PsO who’d already tangoed with other IL-17 inhibitors. Spoiler: 86 % hit IGA 0/1 and PASI 90, while 63 % nailed PASI 100. Not bad for so-called “tough” patients.Expect quick-hit pearls on why dual IL-17 A + F blockade matters, how to frame the switch and treatment class conversation in 30 seconds, and why starting with your heaviest hitter first-line might be a good real world strategy️‍♀️💡🎯 Learning ObjectivesDecode the Data 📊Translate 16-week real-world outcomes (IGA 0/1, PASI 90/100) into day-to-day decision-making for IL-17–experienced psoriasis patients.Master the Switch 🔄Compare primary vs secondary non-responders—and justify when intra-class IL-17 switching still makes clinical (and payer) sense.Counsel with Confidence 🗣️Craft a 30-60-second convo to prep patients to set realistic skin clearance expectations.Rethink the Ladder 🪜Debate first-line versus “last-resort” positioning the current IL-17 vs IL-23 landscape.Plan for Durability 📅Identify unanswered questions—1-year persistence, multi-failure cohorts—and how ongoing real-world follow-up could reshape treatment algorithms.🔔 Hit play, level up your treatment playbook, and maybe even shave a few strokes off your psoriasis management game. #SkinAndJointsPodcast #PsoriasisPearls 🩺EXCLUSIVE TO THE SKIN AND JOINTS PODCAST About Dr. Ron Vender MD, FRCPCDermatologist | HamiltonDr. Ron Vender is a Dermatologist who currently practices in Hamilton. He is the founder and director of Dermatrials Research Incorporated and Venderm Innovations in Psoriasis. He has participated as principal investigator in over 100 clinical trials. He is Associate Clinical Professor at McMaster University in the Department of Medicine, Division of Dermatology. Dr. Vender serves on the editorial board of the Journal of Cutaneous Medicine and Surgery reviewer for the JEADV, JAAD, and BJD. He is one of eight Canadians elected to the International Psoriasis Council, a member of the Canadian Professors of Dermatology and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. He represents Canada on several global educational steering committees as well as international advisory boards. He has published over 100 peer-reviewed manuscripts and has had posters, abstracts and lectures presented internationally. About Dr.Jensen Yeung MD, FRCPCDermatologist | Toronto Dr. Jensen Yeung obtained a B.Sc. (Honours) and MD from McMaster University in 2001. In the same year, he began his dermatology residency training at the University of Toronto. During his residency training, he spent 6 months in Australia, New York, and Boston gaining clinical experience and acquiring the newest knowledge in the field of melanoma and dermoscopy from leading experts. In 2005, he was selected by the residency program as the co-chief resident for the year. Having obtained his board certification from the Royal College of Physicians and Surgeons of Canada in 2006, he joined the Faculty of Dermatology at the University of Toronto, where he ran teaching clinics at both Women’s College Hospital and the Sunnybrook Health Sciences Centre. In 2007, he was promoted to the position of medical director for the RKS Dermatology Program at Women’s College Hospital, where he ran a melanoma, psoriasis, and General Dermatology clinic. In 2013, he switched from RKS to PERC and took on the new role as the medical director of PERC (phototherapy education and research centre) where he runs weekly psoriasis/phototherapy clinic. In 2014, he and Dr. Dana Jerome started a monthly combined psoriasis/psoriatic arthritis clinic at PERC. In 2011, he joined Dr. Kim Papp’s research facility in Waterloo and has participated in over 200 phase 1 to 4 clinical trials. He has also supervised and mentored many research students and residents, which has led to around 180 peer-reviewed publications. He is an associate editor at JCMS and Canadian Dermatology Today. He has received a number of teaching awards including the best resident teacher award in 2005, the 2008 Women’s College Hospital Department of Medicine Postgraduate Teaching Award, the 2009 University of Toronto Dermatology Postgraduate Program Staff Teaching Award, and the 2023 University of Toronto Department of Medicine Award for Excellence in Postgraduate Teaching.📻www.skinandjoints.ca✉️info@...
    続きを読む 一部表示
    33 分
  • Navigating the Pharmacy Acne Aisle with Dr. Sonya Abdulla: Ingredient Deepdive PART 3

    Navigating the Pharmacy Acne Aisle with Dr. Sonya Abdulla: Ingredient Deepdive PART 3
    2025/05/20

    🎙️ Before the Referral to Dr. Abdulla: Filling Your Acne 🛒 ‘Shopping Cart’—Rapid-Fire Ingredients & Real-World Care Considerations (Part 3 of 3)

    Episode description

    While your patient sits on a six-month wait-list for dermatology, their acne isn’t taking a holiday.

    In the finale of our ingredient deep-dive mini-series, Dr. Sonya Abdulla add to the bulging cart: neo-glucosamine 🧴, glycerin 💧, niacinamide ✨, probiotics 🦠, peptides 🧬, and the aisle heroes—salicylic acid, benzoyl peroxide, and retiinol

    Dr. Abdulla also tackles a practice gap too many overlook: the act of referral is not a management plan.

    Tune in for bite-sized, practical scripts for product layering ➡️🧖‍♀️➡️🌞 and a myth-busting look at the microbiome 🤯

    Powered by a rapid-fire Q&A, and (yes) a self-checkout beep 🔊, this episode hands you an expert toolkit 🧰 to keep acne care moving—because ⏱️ timing is everything.

    Learning objectives

    ⏩ – Identify two evidence-based prescription or OTC therapies to start while patients await referral.

    🧪 – Compare how neo-glucosamine, glycerin, niacinamide, salicylic acid, benzoyl peroxide & retinol hit the four pillars of acne pathophysiology.

    🔍 – Summarize current evidence (and limits) for probiotics & peptides in acne care, guiding realistic patient expectations.

    🤝 – List practical tips and resources that keep pharmacists, GPs & dermatologists co-aligned along the acne journey.


    #SkinAndJointsPodcast #AcneCare #DermTips #PrimaryCare #PharmacyPearls #SkinBarrier #IngredientDeepDive #StartLowGoSlow #DermEducation #Neutrogena #AcneAisleMiniSeries #SkinAndJointsPodcast #PharmToDerm 🛍️💡

    Made possible with the support of Kenvue Neutrogena

    Opinions are for educational purposes only and do not replace individualized medical advice.

    ABOUT Dr. Sonya Abdulla

    Dermatologist, TORONTO, ON

    Dr. Abdulla is a board-certified dermatologist in Canada and the USA and has a blended medical and aesthetic dermatology practice at Dermatology on Bloor in Toronto. She earned her degree from the University of Ottawa, where she was awarded the Dr. André Peloquin Award for excellence in patient care. She completed additional Fellowship training in Dermatologic Laser Surgery and Aesthetic Medicine at the University of Toronto.

    Dr. Abdulla is an active member of the Canadian Dermatology Association, American Academy of Dermatology, American Society of Dermatologic Surgery, European Academy of Dermatology and Venereology, Ontario Medical Association, and Canadian Medical Association. Additionally, she is a published author with numerous articles in peer-reviewed scientific journals.

    📻www.skinandjoints.ca

    ✉️info@skinandjoints.ca
    続きを読む 一部表示
    19 分

Skin and Joints Podcastに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。